News
PGNY
15.44
+3.14%
0.47
Progyny's (NASDAQ:PGNY) Solid Earnings Have Been Accounted For Conservatively
Simply Wall St · 3d ago
Zoetis: This Beautifully Boring, Slow-Growing Compounder Is A Buy
Seeking Alpha · 6d ago
Weekly Report: what happened at PGNY last week (1111-1115)?
Weekly Report · 6d ago
Progyny: After A Terrible Year, I'm Out (Rating Downgrade)
Seeking Alpha · 6d ago
Progyny Is Maintained at Overweight by Barclays
Dow Jones · 11/14 14:16
Progyny Price Target Cut to $17.00/Share From $30.00 by Barclays
Dow Jones · 11/14 14:16
Barclays Maintains Overweight on Progyny, Lowers Price Target to $17
Benzinga · 11/14 14:06
Progyny Third Quarter 2024 Earnings: Misses Expectations
Simply Wall St · 11/14 12:05
PROGYNY <PGNY.O>: BARCLAYS CUTS TARGET PRICE TO $17 FROM $30
Reuters · 11/14 11:25
Progyny price target lowered to $17 from $30 at Barclays
TipRanks · 11/14 10:35
Progyny Faces Challenges with Lowered Expectations Amid New Initiatives
TipRanks · 11/14 07:37
U.S. RESEARCH ROUNDUP-Cisco, Freshpet, Nvidia
Reuters · 11/14 07:02
PROGYNY INC <PGNY.O>: JEFFERIES CUTS TARGET PRICE TO $19 FROM $24
Reuters · 11/14 06:50
Why Progyny Stock Crashed Today
The Motley Fool · 11/13 21:40
BUZZ-U.S. STOCKS ON THE MOVE-Charter Communications, BioNTech, Big US banks
Reuters · 11/13 18:43
Progyny CEO Says Election Didn't Contribute to Weak 3Q -- Market Talk
Dow Jones · 11/13 18:24
Progyny price target lowered to $19 from $24 at Jefferies
TipRanks · 11/13 18:15
Progyny Isn't Sure Why Its Members Aren't Pursuing More Fertility Care -- Market Talk
Dow Jones · 11/13 18:08
Wednesday Sector Laggards: Hospital & Medical Practitioners, Communicationss Services
NASDAQ · 11/13 16:59
Progyny stock plunges 18% amid lowered guidance, Truist downgrade
Seeking Alpha · 11/13 16:14
More
Webull provides a variety of real-time PGNY stock news. You can receive the latest news about Progyny, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About PGNY
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.